Seroprevalence of COVID-19 in Oran: Cross-Sectional Study-Reference-Cited by-同舟云学术

Seroprevalence of COVID-19 in Oran: Cross-Sectional Study

Published:2023-08-17 Issue:4 Volume:11 Page:
ISSN:2165-0497
Container-title:Microbiology Spectrum
language:en
Short-container-title:Microbiol Spectr

Author:

Dali-Ali Abdessamad¹²^ORCID,Derkaoui Dalia Kheira³,Zina Mohamed⁴,Oukebdane Asmaa⁵

Affiliation:

1. University of Oran 1: Ahmed Ben Bella, Faculty of Medicine, Oran, Algeria

2. Department of Epidemiology and Preventive Medicine at EHUO, Oran, Algeria

3. University of Oran 2: Faculty of Sciences, Department of Biology, Oran, Algeria

4. Public Establishment of Proximity Care in Boutlellis, Department of Epidemiology and Preventive Medicine, Boutlellis, Oran, Algeria

5. Canastel Specialized Hospital, Ophthalmology Department, Oran, Algeria

Abstract

This is the first and only seroprevalence study of COVID-19 conducted in the general population in Algeria prior to the national vaccination campaign against COVID-19. The significance of this study lies in its contribution to our understanding of the spread of the virus in the population before the implementation of the vaccination program.

Publisher

American Society for Microbiology

Subject

Infectious Diseases,Cell Biology,Microbiology (medical),Genetics,General Immunology and Microbiology,Ecology,Physiology

Link

https://journals.asm.org/doi/pdf/10.1128/spectrum.00876-23

Reference30 articles.

1. World Health Organization. 2020. WHO Coronavirus Disease (Covid-19) Dashboard 2020. WHO Geneva Switzerland. https://covid19.who.int.

2. National Institute of Public Health. 2021. Covid-19 pandemic Algeria. Bulletin no. 224. Epidemiological situation as of June 28 2021. National Institute of Public Health Alger Algeria.

3. Visualizing the invisible: The effect of asymptomatic transmission on the outbreak dynamics of COVID-19

4. COVID-19 antibody seroprevalence in Santa Clara County, California

5. Detection and analysis of nucleic acid in various biological samples of COVID-19 patients